Heartbeam Inc
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-… Read more
Heartbeam Inc (BEAT) - Net Assets
Latest net assets as of September 2025: $406.00K USD
Based on the latest financial reports, Heartbeam Inc (BEAT) has net assets worth $406.00K USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.88 Million) and total liabilities ($2.47 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $406.00K |
| % of Total Assets | 14.12% |
| Annual Growth Rate | -7.23% |
| 5-Year Change | N/A |
| 10-Year Change | -97.82% |
| Growth Volatility | 159.13 |
Heartbeam Inc - Net Assets Trend (2003–2024)
This chart illustrates how Heartbeam Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Heartbeam Inc (2003–2024)
The table below shows the annual net assets of Heartbeam Inc from 2003 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $1.65 Million | -89.62% |
| 2023-12-31 | $15.94 Million | +571.31% |
| 2022-12-31 | $2.37 Million | -82.30% |
| 2021-12-31 | $13.41 Million | +380.25% |
| 2020-12-31 | $-4.79 Million | -28.39% |
| 2019-12-31 | $-3.73 Million | -101.20% |
| 2018-12-31 | $310.49 Million | +24.34% |
| 2017-12-31 | $249.70 Million | +79.75% |
| 2016-12-31 | $138.91 Million | +82.96% |
| 2015-12-31 | $75.93 Million | +19.24% |
| 2014-12-31 | $63.68 Million | -4.72% |
| 2013-12-31 | $66.83 Million | -4.53% |
| 2012-12-31 | $70.00 Million | -10.26% |
| 2011-12-31 | $78.00 Million | -42.19% |
| 2010-12-31 | $134.93 Million | -9.66% |
| 2009-12-31 | $149.35 Million | -0.51% |
| 2008-12-31 | $150.12 Million | +658.78% |
| 2007-12-31 | $-26.87 Million | -35.29% |
| 2006-12-31 | $-19.86 Million | -618.67% |
| 2004-12-31 | $-2.76 Million | -134.54% |
| 2003-12-31 | $8.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Heartbeam Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5627300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $3.00K | 0.18% |
| Other Components | $57.92 Million | 3502.06% |
| Total Equity | $1.65 Million | 100.00% |
Heartbeam Inc Competitors by Market Cap
The table below lists competitors of Heartbeam Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
FORTEC Elektronik AG
F:FEV
|
$35.44 Million |
|
Cho Kwang Leat
KO:004700
|
$35.45 Million |
|
Alicon Castalloy Limited
NSE:ALICON
|
$35.46 Million |
|
Seronics Co. Ltd
KQ:042600
|
$35.47 Million |
|
PetMed Express Inc
NASDAQ:PETS
|
$35.41 Million |
|
Heran Co Ltd
TW:5283
|
$35.41 Million |
|
PT Wintermar Offshore Marine Tbk
F:W6O
|
$35.40 Million |
|
Bcl Industries Limited
NSE:BCLIND
|
$35.38 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Heartbeam Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 15,937,000 to 1,654,000, a change of -14,283,000 (-89.6%).
- Net loss of 19,448,000 reduced equity.
- New share issuances of 730,000 increased equity.
- Other factors increased equity by 4,435,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-19.45 Million | -1175.82% |
| Share Issuances | $730.00K | +44.14% |
| Other Changes | $4.43 Million | +268.14% |
| Total Change | $- | -89.62% |
Book Value vs Market Value Analysis
This analysis compares Heartbeam Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 20.94x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.39x to 20.94x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | $3.30 | $1.30 | x |
| 2004-12-31 | $-0.97 | $1.30 | x |
| 2006-12-31 | $-1.33 | $1.30 | x |
| 2007-12-31 | $-1.79 | $1.30 | x |
| 2008-12-31 | $6.63 | $1.30 | x |
| 2009-12-31 | $6.28 | $1.30 | x |
| 2010-12-31 | $5.60 | $1.30 | x |
| 2011-12-31 | $3.19 | $1.30 | x |
| 2012-12-31 | $2.81 | $1.30 | x |
| 2013-12-31 | $2.62 | $1.30 | x |
| 2014-12-31 | $2.41 | $1.30 | x |
| 2015-12-31 | $2.61 | $1.30 | x |
| 2016-12-31 | $4.56 | $1.30 | x |
| 2017-12-31 | $8.25 | $1.30 | x |
| 2018-12-31 | $8.68 | $1.30 | x |
| 2019-12-31 | $-0.46 | $1.30 | x |
| 2020-12-31 | $-0.59 | $1.30 | x |
| 2021-12-31 | $1.72 | $1.30 | x |
| 2022-12-31 | $0.29 | $1.30 | x |
| 2023-12-31 | $0.78 | $1.30 | x |
| 2024-12-31 | $0.06 | $1.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Heartbeam Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1175.82%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.98x
- Recent ROE (-1175.82%) is below the historical average (-99.46%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | -158.50% | -160.04% | 0.36x | 2.77x | $-13.48 Million |
| 2004 | 0.00% | -94.22% | 0.97x | 0.00x | $-20.67 Million |
| 2006 | 0.00% | -22.54% | 1.98x | 0.00x | $-5.66 Million |
| 2007 | 0.00% | -0.49% | 0.71x | 0.00x | $2.33 Million |
| 2008 | 6.13% | 7.64% | 0.73x | 1.10x | $-5.81 Million |
| 2009 | -13.71% | -14.56% | 0.84x | 1.13x | $-35.41 Million |
| 2010 | -14.72% | -16.56% | 0.77x | 1.16x | $-33.35 Million |
| 2011 | -78.75% | -51.61% | 1.25x | 1.22x | $-69.22 Million |
| 2012 | -17.43% | -10.94% | 1.24x | 1.29x | $-19.20 Million |
| 2013 | -10.95% | -5.65% | 1.48x | 1.31x | $-14.00 Million |
| 2014 | -15.38% | -5.88% | 1.33x | 1.96x | $-16.16 Million |
| 2015 | 9.78% | 4.16% | 1.44x | 1.64x | $-164.60K |
| 2016 | 38.47% | 25.65% | 1.05x | 1.43x | $39.55 Million |
| 2017 | -6.36% | -5.56% | 0.55x | 2.09x | $-41.03 Million |
| 2018 | 13.79% | 10.72% | 0.68x | 1.89x | $11.77 Million |
| 2019 | 0.00% | -0.18% | 62729.57x | 0.00x | $-405.30K |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-869.50K |
| 2021 | -33.02% | 0.00% | 0.00x | 1.04x | $-5.77 Million |
| 2022 | -540.31% | 0.00% | 0.00x | 1.70x | $-13.06 Million |
| 2023 | -91.86% | 0.00% | 0.00x | 1.07x | $-16.23 Million |
| 2024 | -1175.82% | 0.00% | 0.00x | 1.98x | $-19.61 Million |
Industry Comparison
This section compares Heartbeam Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $79,108,599
- Average return on equity (ROE) among peers: -247.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Heartbeam Inc (BEAT) | $406.00K | -158.50% | 6.08x | $35.43 Million |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $-198.56K | 0.00% | 0.00x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |